NVE Corporation Reports Q2 2027 Revenue Decline Amid Defense and Medical Inventory Fluctuations
NVE Corporation (NVEC) reported a second-quarter total revenue of $5.83 million, an 8% decrease compared to the prior year. This decline was primarily driven by a 9% drop in product sales resulting from short-term inventory adjustments at a major medical device customer and significant volatility in defense sector procurement cycles. Despite the quarterly dip, the company's first-half performance remains strong, with total revenue reaching $16.87 million, up 36% year-over-year. NVE maintained high profitability with a gross margin of 78% and an operating margin of 55%, aided by a lower effective tax rate of 14%. Management expects second-half performance to remain consistent with the first half of the fiscal year.
Tickers: $NVEC
Topics: Defense sales decrease Dividend announcement Financial guidance Net Income Revenue decline
Read the full article at Motley Fool
Part of the story NVE Reports 36% Revenue Growth Amid Commercial Demand and Medical Sector Headwinds (3 articles)